NO976048L - Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser - Google Patents

Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser

Info

Publication number
NO976048L
NO976048L NO976048A NO976048A NO976048L NO 976048 L NO976048 L NO 976048L NO 976048 A NO976048 A NO 976048A NO 976048 A NO976048 A NO 976048A NO 976048 L NO976048 L NO 976048L
Authority
NO
Norway
Prior art keywords
prophylaxis
pharmaceutical
treatment
gastrointestinal disorders
pct
Prior art date
Application number
NO976048A
Other languages
English (en)
Norwegian (no)
Other versions
NO976048D0 (no
Inventor
Christoph De Haen
Luigia Gozzini
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of NO976048D0 publication Critical patent/NO976048D0/no
Publication of NO976048L publication Critical patent/NO976048L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Confectionery (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO976048A 1995-06-23 1997-12-22 Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser NO976048L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI001359A IT1276783B1 (it) 1995-06-23 1995-06-23 Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
PCT/EP1996/002650 WO1997000688A1 (en) 1995-06-23 1996-06-19 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders

Publications (2)

Publication Number Publication Date
NO976048D0 NO976048D0 (no) 1997-12-22
NO976048L true NO976048L (no) 1998-02-23

Family

ID=11371866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO976048A NO976048L (no) 1995-06-23 1997-12-22 Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser

Country Status (18)

Country Link
US (1) US6007808A (es)
EP (1) EP0833644B1 (es)
JP (1) JPH11507934A (es)
CN (1) CN1082373C (es)
AT (1) ATE234623T1 (es)
AU (1) AU707399B2 (es)
BR (1) BR9609413A (es)
CA (1) CA2219739A1 (es)
DE (2) DE833644T1 (es)
DK (1) DK0833644T3 (es)
ES (1) ES2194107T3 (es)
HU (1) HUP9901707A3 (es)
IT (1) IT1276783B1 (es)
MX (1) MX9709238A (es)
NO (1) NO976048L (es)
NZ (1) NZ312121A (es)
WO (1) WO1997000688A1 (es)
ZA (1) ZA965235B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
WO2001083700A2 (en) * 2000-05-03 2001-11-08 University Of Maryland, Baltimore Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal
US7112570B2 (en) * 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
JP4559380B2 (ja) * 2002-03-01 2010-10-06 日清ファルマ株式会社 肝疾患治療剤
WO2004009800A1 (ja) * 2002-07-22 2004-01-29 Meito Sangyo Co., Ltd ラクトバシラス・カゼイ 亜種 カゼイ増殖促進用組成物
DK175877B1 (da) * 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
US7384628B2 (en) * 2003-06-23 2008-06-10 Agtech Products, Inc. Lactic acid bacteria and its use in direct-fed microbials
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
BRPI0611492B1 (pt) * 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
CA2609617C (en) * 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
JPWO2007119502A1 (ja) * 2006-03-23 2009-08-27 協和発酵バイオ株式会社 便通改善剤
PL2004201T3 (pl) * 2006-03-29 2019-02-28 Nestec S.A. Suplementy diety zawierające probiotyki
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
CN101259140B (zh) * 2007-03-08 2012-08-22 重庆北碚现代应用药物研究所 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2011009848A2 (en) 2009-07-20 2011-01-27 Bracco Spa Therapeutic use of probiotics
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP5468183B2 (ja) 2011-12-28 2014-04-09 株式会社山田養蜂場本社 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5397803A (en) * 1985-09-12 1995-03-14 Brigham And Women's Hospital Use of glutamine to reduce rate of pathogenic microorganism infection
JPH0367046A (ja) * 1989-08-05 1991-03-22 Mitsubishi Motors Corp エンジンの吸入空気量制御装置
CN1105544A (zh) * 1994-09-09 1995-07-26 扬州大学农学院 一种制取活性乳酸菌口服液的方法
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding

Also Published As

Publication number Publication date
ES2194107T3 (es) 2003-11-16
US6007808A (en) 1999-12-28
HUP9901707A2 (hu) 1999-09-28
AU6357596A (en) 1997-01-22
EP0833644A1 (en) 1998-04-08
DE69626818D1 (de) 2003-04-24
DE833644T1 (de) 1998-09-03
ITMI951359A0 (it) 1995-06-23
DK0833644T3 (da) 2003-07-21
MX9709238A (es) 1998-03-31
ITMI951359A1 (it) 1996-12-23
BR9609413A (pt) 1999-05-18
IT1276783B1 (it) 1997-11-03
ATE234623T1 (de) 2003-04-15
JPH11507934A (ja) 1999-07-13
CA2219739A1 (en) 1997-01-09
HUP9901707A3 (en) 2001-04-28
WO1997000688A1 (en) 1997-01-09
EP0833644B1 (en) 2003-03-19
CN1188413A (zh) 1998-07-22
CN1082373C (zh) 2002-04-10
NZ312121A (en) 1999-03-29
AU707399B2 (en) 1999-07-08
DE69626818T2 (de) 2003-11-20
ZA965235B (en) 1997-01-09
NO976048D0 (no) 1997-12-22

Similar Documents

Publication Publication Date Title
NO976048L (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
NO20045323L (no) Antistoffer
NO953187D0 (no) Imidazopyridiner og deres anvendelse ved behandling av mave-tarm-sykdommer
BG101118A (en) Therapeutical compounds
BR9914044A (pt) ésteres tetrahidropirido
PT763037E (pt) Derivados de pirrol ¬a|-anelizados e sua utilizacao farmaceutica
BR9809185A (pt) Diidropiranos fundidos
NO952310L (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av Parkinsons sykdom og Parkinsonianske syndromer
PT741716E (pt) Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
FI961564A (fi) Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
DK0711283T3 (da) Tetrahydro-1H-benzazepinoner og hexahydroazepinoner som selektive cholecystokinin-B-receptorantagonister
DK0748314T3 (da) Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
DK0707477T3 (da) Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo
ATE294802T1 (de) 3-alkylimidazopyridine
MX9804579A (es) Composiciones que contienen bismuto para la prevencion y tratamiento de trastornos gastrointestinales.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application